HP
Helix Pharma
Pharma & Life Sciences

A global pharma cuts MLR review cycles 64% with an evidence-grounded, regulator-defensible agent stack across 14 markets.

↓ 64%
Median MLR cycle time
2.6×
Reviewer throughput
0
Audit findings on AI-assisted reviews
The challenge

Helix's medical, legal and regulatory (MLR) review was the bottleneck for promotional content launches across 14 markets. Cycle times averaged 11 business days. Reviewer fatigue was high. The launch backlog was costing meaningful share-of-voice.

The solution

Synaptix deployed an MLR pre-review agent stack: a claims-extraction agent identifies promotional claims, a reference-matching agent links each claim to approved sources, a regulatory-reasoning agent flags risk against country-specific guidance (FDA, EMA, PMDA, etc.), and a reviewer-assist UI produces a triaged, pre-annotated piece for the human MLR team.

"Our launches are no longer paced by MLR. The audit trail is cleaner than what we had with humans alone."

Dr. Hannes Müller, Head of Global MLR Operations, Helix Pharma
More stories

Ready to operationalize your agents?

Talk to our team about a pilot on Synaptix Cloud or on-prem.